DRAFT– 

– January28,2010

 

 

 











 









 





 









 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) 

Centers for Disease Control and Prevention
 

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
 

February 24-25, 2010 

AGENDA ITEM	 PURPOSE 

Wednesday, February 24, 2010 

8:00 Welcome & Introductions 

8:30 Human Papillomavirus (HPV) Vaccine 

Introduction 

Quadrivalent HPV vaccine for adult women 

Efficacy in women 24 through 45 years of age 

Epidemiology and natural history 

Cost effectiveness 

Special situations 

Quadrivalent HPV vaccine in males 

Efficacy in the prevention of anal precancers 

Bivalent and quadrivalent HPV vaccine cross 

protection data 

Information 

& 

Discussion 

Information 

& 

Discussion 

10 :15	 Break 

10:45 13-Valent Pneumococcal Conjugate Vaccine (PCV13) 

Introduction 

Recommendation for routine infant immunization 

with PCV13 

VFC vote 

Program implementation - transition from PCV7 to 

PCV13 

Information 

Discussion 

Vote 

VFC 

Information 

12:15	 Lunch 

1:15 Hepatitis Vaccines 

Update on Hepatitis Vaccines Work Group 

Diabetes and liver disease 

1:45 Influenza Vaccines 

Introduction 

2009-10 Season review Information 

& 

Influenza epidemiology Discussion 

Virology 

3:45	 Break 

PRESIDER/PRESENTER(s) 

Dr. Carol Baker (Chair, ACIP) 

Dr. Larry Pickering 

(Executive Secretary, ACIP; CDC) 

Dr. Janet Englund (ACIP, WG Chair)
 

Dr. Richard Haupt (Merck)
 

Dr. Eileen Dunne (CDC/NCHHSTP)
 

Dr. Harrell Chesson (CDC/NCHHSTP)
 

Dr. Deblina Datta (CDC/NCHHSTP)
 

Dr. Richard Haupt (Merck)
 

Dr. Lauri Markowitz 

(CDC/NCHHSTP) 

Dr. Kathy Neuzil (ACIP, member) 

Dr. Pekka Nuorti (CDC/NCIRD) 

Dr. Jeanne Santoli 

 (CDC/ NCIRD) 

Dr Abigail Shefer (CDC/ NCIRD) 

Dr. Mark Sawyer (ACIP, WG Chair)

Dr. John W.Ward (CDC/NCHHSTP)

Dr. Kathy Neuzil (Chair, WG ACIP)
 

Dr. Anthony Fiore (CDC/NCIRD)
 

Dr. James Singleton (CDC/NCIRD)
 

Dr. Anthony Fiore (CDC/NCIRD)
 

Dr. Lyn Finelli (CDC/NCIRD)
 

Dr. Nancy Cox (CDC/NCIRD)
 

Page 1 
DRAFT– 

– January28,2010
 

 











 

 

8:55	 Meningococcal Vaccine 

Introduction 

Provider attitudes towards infant meningococcal 

 vaccination 

Cost-effectiveness analysis of infant meningococcal 

 vaccines 

Review of rationale for no routine recommendation 

and considerations for permissive use of 

meningococcal conjugate vaccines in infants 

 

 









 

 

Wednesday, February 24, 2010 (cont’d) 

4:00 Influenza Vaccines (cont’d) 

High dose influenza vaccine for persons 65 and older 

Cell culture derived vaccine for 18 through 49 years 

Work Group discussion 

Annual influenza prevention and control 

recommendations 

VFC vote 

5:50 Public Comment 

6:05 Adjourn 

Thursday, February 25, 2010 

8:00	 Unfinished Business 

8:30 Agency Updates (CDC, CMS, DOD, DVA, FDA, HRSA, IHS, 

NIH, NVAC, NVPO) 

8:45	 Update: National Vaccine Plan 

10:10	 Break 

10:25	 Ongoing Mumps Outbreaks, Northeastern United 

States, July 2009 - present 

10:35	 Rotavirus Vaccines 

 Severe Combined Immunodeficiency (SCID) and 

rotavirus vaccine 

10:50	 Vaccine Supply 

 Update on vaccine supply 

11:05	 Evidence Based Recommendations Work Group 

 Introduction 

 Methodological standards for guidelines 

 Guidelines for grading the quality of evidence 

 Guidelines for synthesizing and presenting 

recommendations 

Information 

& 

Discussion 

Vote 

VFC 

Information 

Information 

Information 

Information

&
 

Discussion
 

Information
 

Information
 

Discussion
 

Information
 

Discussion
 

Information
 

Information
 

Discussion
 

Dr. David Greenberg (sanofi)
 

Dr. Manon Cox (Protein Sciences)

Dr. Neuzil and Dr. Fiore
 

Dr. Fiore (CDC/NCIRD)
 

Dr. Jeanne Santoli (CDC/NCIRD)
 

Dr. Carol Baker (Chair, ACIP) 

ACIP Ex Officio Members 

Dr. Bruce Gellin (HHS/OS) 

Dr. Cody Meissner (ACIP, WG Chair) 

Dr. Mandy Allison 

 (University of Colorado) 

Dr. Ismael Ortega-Sanchez 

 (CDC/NCIRD) 

Dr. Amanda Cohn (CDC/NCIRD) 

Dr. Kathleen Gallagher 

(CDC/NCIRD) 

Dr. Catherine Yen (CDC/NCIRD) 

Dr. Jeanne Santoli 

(CDC/ NCIRD) 

Dr. Jonathon Temte 

 (ACIP, WG Chair) 

Dr. Faruque Ahmed (CDC/NCIRD) 

Dr. Craig Umscheid 

 (University of Pennsylvania) 

Dr. Faruque Ahmed (CDC/NCIRD) 

Page 2 
DRAFT– 

– January28,2010
 

ACIP Advisory Committee on Immunization Practices

CDC Centers for Disease Control & Prevention 

CMS Centers for Medicare and Medicaid Services 

DBD Division of Bacterial Diseases [of NCIRD] 

DOD Department of Defense 

DGMQ Division of Global Migration and Quarantine 

DHQP Division of Healthcare Quality Promotion 

DSTDP Division of Sexually Transmitted Diseases Prevention [of NCHHSTP] 

DVA Department of Veterans Affairs 

DVBID Division of Vector-Borne Infectious Diseases 

DVD Division of Viral Diseases [of NCIRD] 

DVH Division of Viral Hepatitis [of NCHHSTP] 

DVRD Division of Viral and Rickettsial Diseases 

FDA Food and Drug Administration 

GID Global Immunization Division 

HHS Health & Human Services 

HRSA Health Resources and Services Administration 

ID Influenza Division [of NCIRD] 

IHS Indian Health Service 

ISD Immunization Services Division [of NCIRD] 

ISO Immunization Safety Office (of CDC/OD/Office of the Chief Science Officer) 

NCHHSTP National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/CCID] 

NCIRD CDC National Center for Immunization & Respiratory Diseases [of CDC/CCID] 

NCPDCID National Center for Preparedness, Detection, and Control of Infectious Diseases 

NCZVED National Center for Zoonotic, Vector-Borne, and Enteric Diseases [of CDC/CCID] 

NIH National Institutes of Health 

NVAC National Vaccine Advisory Committee 

NVPO National Vaccine Program Office 

OCSO Office of the Chief Science Officer 

OD Office of the Director [of CDC] 

OS Office of the Secretary 

TBD To be determined 

WG Wo rk Group 

 

12:20 Public Comment 

12:35 Adjourn 

Acronyms 

This document can be found on the CDC website at: 

http://www.cdc.gov/vaccines/recs/acip/downloads/agenda-feb10.pdf 

Page 3